Previous Close | 2.82 |
Open | 2.82 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 2.76 - 2.86 |
52 Week Range | 2.76 - 4.60 |
Volume | 3,825,787 |
Avg. Volume | 2,177,300 |
Market Cap | 819.099M |
Beta | 1.12 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.25 |
Earnings Date | May 3, 2017 - May 8, 2017 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 7.60 |
Investors need to pay close attention to Amarin (AMRN) stock based on the movements in the options market lately.
BEDMINSTER, N.J., and DUBLIN, Ireland, April 23, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
NEW YORK, April 13, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
BEDMINSTER, N.J. and DUBLIN, Ireland, April 12, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
Amarin Corporation plc (AMRN) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
BEDMINSTER, N.J. and DUBLIN, Ireland, April 12, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
Stock Monitor: Pernix Therapeutics Holdings Post Earnings Reporting LONDON, UK / ACCESSWIRE / April 6, 2018 / Active-Investors.com has just released a free research report on Amarin Corp. PLC (NASDAQ: ...
Amarin has needle-moving news that's fast-approaching.
BEDMINSTER, N.J. and DUBLIN, Ireland, April 04, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
BEDMINSTER, N.J., and DUBLIN, Ireland, April 04, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
Surging implied volatility makes Amarin (AMRN) stock lucrative to the option traders.
Biotech M&A activity took a bit of a breather in 2017, but expect a new wave of deals in 2018.
Q4 2017 Amarin Corporation PLC Earnings Call
BEDMINSTER, N.J. and DUBLIN, Ireland, March 29, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
BEDMINSTER, N.J. and DUBLIN, Ireland, March 28, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
BEDMINSTER, N.J. and DUBLIN, Ireland, March 27, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
BEDMINSTER, N.J. and DUBLIN, Ireland, March 21, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
Alibaba may make the headlines, but here are three other stocks that are equally strong investment opportunities.
NEW YORK, March 16, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
BEDMINSTER, N.J. and DUBLIN, Ireland, March 12, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
BEDMINSTER, N.J. and DUBLIN, Ireland, March 12, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
Jim Cramer zooms through his take on callers' favorite stocks, including a mea culpa on one oil play.
BEDMINSTER, N.J., and DUBLIN, Ireland, March 05, 2018-- Amarin Corporation plc today announced that, in connection with its previously announced underwritten public offering of American Depositary Shares, ...
Surging implied volatility makes Amarin (AMRN) Stock lucrative to the option traders.
Jim Cramer zooms through his take on callers' favorite stocks, including a mea culpa on one oil play.